Charlot Biosciences Inc.
Irvine, CA
- UEI
- D9CGYMBDQAA5
- CAGE
- 7RE34
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- California Institute for Telecommunication and Information Technology, 4100 E Peltason Dr, Irvine, CA 92617, USA
- Website
- cbio.io
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rapid pathogen threat detection in aerial and field environments | Air Force Research Laboratory | $749,574 | |
| Medical r & d DHA sbir 20.2 phase i purchase order for "rapid detection of bacteriophage susceptibility in… | Medical Command | $249,534 | |
| Rapid pathogen threat detection in aerial and field environments | Air Force Research Laboratory | $49,869 |
About Charlot Biosciences Inc.
Charlot Biosciences Inc. is a minority-owned, self-certified small disadvantaged business that provides research and development services related to pathogen detection and antimicrobial resistance. The company has received several Small Business Innovation Research (SBIR) awards from federal agencies such as the Department of the Air Force Materiel Command Research Laboratory and the Defense Health Agency.
Charlot Biosciences Inc. has received two SBIR Phase I and one SBIR Phase II contract awards from the Department of the Air Force Materiel Command Research Laboratory for developing rapid pathogen threat detection technologies in aerial and field environments. The Phase II award, a $749,574 firm-fixed-price contract set aside for small businesses, aims to develop a system for rapid pathogen detection in aerial and field environments. The company has also received a $249,534 Phase I SBIR award from the Defense Health Agency for a project titled "Rapid Detection of Bacteriophage Susceptibility in Antibiotic-Resistant Pathogens Using Cellphoresis," which is focused on addressing antimicrobial resistance. All of these awards were set aside for small businesses and were granted to Charlot Biosciences Inc. as a prime contractor.
Quick answers
What is Charlot Biosciences Inc.'s UEI?
Charlot Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is D9CGYMBDQAA5.
What is Charlot Biosciences Inc.'s CAGE code?
Charlot Biosciences Inc.'s CAGE code is 7RE34.
What is Charlot Biosciences Inc.'s primary NAICS code?
Charlot Biosciences Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Charlot Biosciences Inc. located?
Charlot Biosciences Inc.'s physical address in SAM.gov is California Institute for Telecommunication and Information Technology, 4100 E Peltason Dr, Irvine, CA 92617, USA.
Is Charlot Biosciences Inc. registered in SAM.gov?
Yes. Charlot Biosciences Inc.'s SAM.gov registration is active through October 30, 2026.
What is Charlot Biosciences Inc.'s most recent federal award?
Charlot Biosciences Inc.'s most recent federal contract award is Rapid pathogen threat detection in aerial and field environments (FA864921P1472), from Air Force Research Laboratory, on August 6, 2021.
On GovTribe
See Charlot Biosciences Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors